# Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)

> **NCT02174874** · — · COMPLETED · sponsor: **Dr. Graham Thompson** · enrollment: 462 (actual)

## Conditions studied

- Acute Gastroenteritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02174874
- **Lead sponsor:** Dr. Graham Thompson
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-05
- **Final completion:** 2014-06
- **Target enrollment:** 462 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02174874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02174874, "Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02174874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*